Thermo Fisher Scientific Tax Reconciliation: Change in Valuation Allowance increased by 100.0% to $0.00 in Q1 2026 compared to the prior quarter.
A negative impact on the rate reconciliation suggests a reduction in the allowance, which can improve net income.
This metric measures the specific impact of adjustments to the valuation allowance for deferred tax assets on the compan...
Commonly disclosed in the effective tax rate reconciliation table of 10-K filings.
cat_tax_reconciliation_valuation_allowance_change| Q1 '25 | Q1 '26 | |
|---|---|---|
| Value | -$0.02 | $0.00 |
| QoQ Change | — | +100.0% |
| YoY Change | — | +100.0% |